Last updated on December 2019

Safety Study of Etripamil Nasal Spray for Patients With Paroxysmal Supraventricular Tachycardia. NODE-303


Brief description of study

NODE-303 is a multi-center, open label (OL) study to evaluate the safety of etripamil NS in patients with Paroxysmal Supraventricular Tachycardia (PSVT). Patients will be provided with an ambulatory Cardiac Monitoring System (CMS) to help document PSVT episodes. The CMS will be self-applied by the patient, when PSVT symptoms begin. Patients will self-administer etripamil NS if vagal maneuver is ineffective. After an episode of PSVT where drug is administered, the patient will return to the investigative site for a study visit and will be given the option to continue in NODE-303 and manage subsequent episodes of PSVT with etripamil NS.

Detailed Study Description

NODE-303 is a multi-center, open label (OL) study to evaluate the safety of etripamil NS in patients with PSVT. Patients will be provided with an ambulatory Cardiac Monitoring System (CMS) to help document PSVT episodes. The CMS will be self-applied by the patient, when PSVT symptoms begin. Patients will self-administer etripamil NS if vagal maneuver is ineffective. After an episode of PSVT where drug is administered, the patient will return to the investigative site for a study visit and will be given the option to continue in NODE-303 and manage subsequent episodes of PSVT with etripamil NS.

The study will include:

A Screening Visit during which the Investigator will verify that the patient meets the eligibility criteria of the NODE-303 study, will obtain the signed informed consent, take blood and urine for laboratory evaluations, and conduct other screening procedures. The informed consent for NODE-303 will be applicable for the initial and all subsequent PSVT episodes. A Baseline Visit during which the site will confirm eligibility, concomitant medications, train the patient on study procedures, and give the patient study drug, patient reported outcome (PRO) materials, and the CMS materials. A Treatment Period during which the patient will complete the monthly PRO survey, self-identify symptoms of PSVT, use the CMS, perform a vagal maneuver (VM), and self-administer etripamil NS if the symptoms do not resolve during or after the VM. Patients may be contacted during this period for reminders and training on what to do during a PSVT episode. Patients will also complete a per episode survey after any PSVT episode they experience. During the Treatment Period, Follow-up Visits will occur at the study site up to 14 days after each episode of PSVT which is treated with etripamil NS, and during which the Investigator will evaluate the results of the last usage of etripamil NS and decide whether the patient can continue in the study and receive a new study drug kit. A Final Study Visit that will occur when a patient discontinues or withdraws from the study, or when the overall study is completed, or the patient has completed the maximum number of doses. NODE-303 will continue until enough documented self-administrations of etripamil NS are included in the safety database to meet regulatory requirements for the etripamil NS development program. The common study end date (CSED) for the entire study will depend on the rate of accrual of the primary endpoint, unique patients with an episode. When the criteria for concluding the study have been met, the Sponsor will announce the common study end date (CSED) for the entire study and sites will be informed in advance to schedule all final patient visits prior to the CSED.

Clinical Study Identifier: NCT04072835

Find a site near you

Start Over

1046

Cottonwood, AZ United States
  Connect »

1121

Fremont, CA United States
  Connect »

1023

Vista, CA United States
  Connect »

1083

West Hills, CA United States
  Connect »

1075

Cutler Bay, FL United States
  Connect »

1106

Daytona Beach, FL United States
  Connect »

1054

Doral, FL United States
  Connect »

1027

Hialeah, FL United States
  Connect »

1032

Hialeah, FL United States
  Connect »

1026

Miami, FL United States
  Connect »

1064

Naples, FL United States
  Connect »

1071

North Miami Beach, FL United States
  Connect »

1009

Orlando, FL United States
  Connect »

1030

Orlando, FL United States
  Connect »

Site 1022

Cumming, GA United States
  Connect »

1053

Tucker, GA United States
  Connect »

1025

West Des Moines, IA United States
  Connect »

1015

Louisville, KY United States
  Connect »

1008

Monroe, LA United States
  Connect »

1070

Shreveport, LA United States
  Connect »

1007

Salisbury, MD United States
  Connect »

1005

Charlotte, NC United States
  Connect »

1065

Charlotte, NC United States
  Connect »

1072

Lenoir, NC United States
  Connect »

1074

Morganton, NC United States
  Connect »

1024

Canton, OH United States
  Connect »

1002

Rapid City, SD United States
  Connect »

1062

Jackson, TN United States
  Connect »

1047

Austin, TX United States
  Connect »

1104

Beaumont, TX United States
  Connect »

1013

Dallas, TX United States
  Connect »

1016

Fort Worth, TX United States
  Connect »

1001

Houston, TX United States
  Connect »

1017

Houston, TX United States
  Connect »

1048

Plano, TX United States
  Connect »

Site 1004

Riverton, UT United States
  Connect »

2010

North Vancouver, BC Canada
  Connect »

2005

Burlington, ON Canada
  Connect »

2006

Oshawa, ON Canada
  Connect »

2011

Greenfield Park, QC Canada
  Connect »

2002

Saint-Jean-sur-Richelieu, QC Canada
  Connect »

5129

Ciudad Autónoma de Buenos Aires, Argentina
  Connect »

3007

Bruxelles, Belgium
  Connect »

5215

Campinas, Brazil
  Connect »

5307

Santiago, Chile
  Connect »

5407

Punta de Cartagena, Colombia
  Connect »

4006

Prague, Czechia
  Connect »

3701

Copenhagen NV, Denmark
  Connect »

3101

Brest Cedex, France
  Connect »

3201

Dortmund, Germany
  Connect »

4101

Budapest, Hungary
  Connect »

6001

Afula, Israel
  Connect »

3301

Torrette, Italy
  Connect »

5018

Monterrey, Mexico
  Connect »

3416

Leiden, Netherlands
  Connect »

4201

Gda?sk, Poland
  Connect »

4301

Cluj-Napoca, Romania
  Connect »

4503

Novosibirsk, Russian Federation
  Connect »

4601

Považská Bystrica, Slovakia
  Connect »

7001

Somerset West, South Africa
  Connect »

3503

Madrid, Spain
  Connect »

4401

Odesa, Ukraine
  Connect »

3602

London, United Kingdom
  Connect »

1042

Bradenton, FL United States
  Connect »

1061

Jacksonville, FL United States
  Connect »

1073

Bossier City, LA United States
  Connect »

1088

Flint, MI United States
  Connect »

1079

Mount Airy, NC United States
  Connect »

1091

Cincinnati, OH United States
  Connect »

5129

Ciudad Autónoma de Buenos Aires, Argentina
  Connect »

2007

Sudbury, ON Canada
  Connect »

4201

Gda?sk, Poland
  Connect »

4601

Považská Bystrica, Slovakia
  Connect »

1098

Anaheim, CA United States
  Connect »

1107

Edgewater, FL United States
  Connect »

1055

Miami, FL United States
  Connect »

1045

Peoria, IL United States
  Connect »

1126

Columbia Falls, MT United States
  Connect »

1069

Dayton, OH United States
  Connect »

5129

Ciudad Autónoma de Buenos Aires, Argentina
  Connect »

2009

Scarborough, ON Canada
  Connect »

4201

Gda?sk, Poland
  Connect »

4601

Považská Bystrica, Slovakia
  Connect »